- Home
- FCCO vs OTLK Comparison
FCCO vs OTLK Comparison
Compare FCCO & OTLK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FCCO | OTLK |
|---|---|---|
| Founded | 1994 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 290.5M | 249.6M |
| IPO Year | 2012 | 2016 |
Fundamental Metrics
Financial Performance| Metric | FCCO | OTLK |
|---|---|---|
| Price | $34.97 | $1.02 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $2.50 |
| AVG Volume (30 Days) | 40.1K | ★ 12.5M |
| Earning Date | 04-22-2026 | 05-14-2026 |
| Dividend Yield | ★ 2.16% | N/A |
| EPS Growth | 36.46 | ★ 55.91 |
| EPS | ★ 0.59 | N/A |
| Revenue | $922,000.00 | ★ $8,146,123.00 |
| Revenue This Year | $30.67 | $1,430.98 |
| Revenue Next Year | $5.87 | $173.23 |
| P/E Ratio | $59.37 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $24.12 | $0.16 |
| 52 Week High | $35.26 | $3.39 |
Technical Indicators
Market Signals| Indicator | FCCO | OTLK |
|---|---|---|
| Relative Strength Index (RSI) | 72.86 | 40.53 |
| Support Level | $29.26 | $0.26 |
| Resistance Level | N/A | $1.95 |
| Average True Range (ATR) | 1.06 | 0.20 |
| MACD | 0.22 | -0.09 |
| Stochastic Oscillator | 94.78 | 21.50 |
Price Performance
Historical ComparisonAbout FCCO First Community Corporation
First Community Corp is a bank holding company. Along with its subsidiaries, it provides various banking products and services for professionals and small and medium-sized businesses, including consumer and commercial banking, mortgage, brokerage and investment, online banking, and insurance services. The company offers checking, savings, money market, individual retirement, and certificates of deposit accounts, and its lending lines include consumer loans, real estate loans, home improvement loans, home loans, flex loans, construction loans, agricultural loans, and others. The company's reportable segments are: Commercial and Retail Banking, which derives maximum revenue; Mortgage Banking; Investment Advisory and Non-Deposit; and Corporate.
About OTLK Outlook Therapeutics Inc.
Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications. The Company have received marketing authorization for an ophthalmic formulation of ONS-5010/LYTENAVA (bevacizumab-gamma) for use in treating wet age-related macular degeneration, or wet AMD, in the European Union, and United Kingdom. The product pipeline includes ONS-5010/LYTENAVA, which is in total eight NORSES; ONS-5010 Clinical Progress, Unmet Patient Needs, New Ophthalmic Anti-VEGF, and Potential First Line Therapy.